Digital Lung Acoustics for Better Insight
Continuously measure patients’ lung sounds including cough and wheeze from anywhere
As Featured In
See the Full Respiratory Picture
Stethoscope auscultation is key in identifying abnormal sounds to diagnose and monitor respiratory diseases, yet it has been limited to in-person, episodic visits. The RESP Biosensor is the first FDA-cleared device to provide a continuous, passive measurement of patients’ lung sounds from hospital to home.
For Clinicians
Enhance surveillance and management of patients with chronic respiratory diseases
For Researchers
Strengthen evidence and insight into subject treatment response in clinical trials
How It Works
An end-to-end solution for remote monitoring of lung health
RESP® Biosensor
Patient receives system and adheres device to their chest with a provided adhesive
Strados™ Mobile App
Patient starts device recording via mobile app, with lung sound data securely transferred to the app
Strados™ Cloud
Cloud securely stores data where lung sounds such as cough and wheeze are identified by either algorithms or trained annotators
750K+
Lung Sounds Captured
20M+
Breaths Captured
4
35
2
1
The Award-Winning Technology Revolutionizing Lung Health
Privacy & Security
Designed for Daily Life
Low-burden, discreet design aids patient comfort while accurately collecting data in the real world.
Global Experience
Used in patients and subjects in four continents and 35 languages.
Beyond Cough
Extended capabilities beyond cough frequency include intensity, bouts, lung sounds and vitals* for a fuller understanding of patient health.
Clinically Validated Accuracy
*Measurement not FDA-cleared
FAQ
Frequently Asked Questions and Technical Specifications
News & Resources
Upcoming Webinar: From Symptoms to Solutions: Enhancing Interstitial Lung Disease (ILD) Trials with Next-Gen Assessments
Join our partner Clario's webinar on April 22nd at 11am EDT. Register Now. Interstitial lung disease (ILD) represents a diverse group of disorders characterized by infiltration of lung parenchyma with extracellular matrix, leading to progressive respiratory impairment...
Strados Labs Introduces Grant Initiative to Accelerate Research into Continuous Lung Sound Monitoring
The new program provides eligible research studies with in-kind support for the use of the RESP® Biosensor system. Philadelphia, PA, March 20, 2025 – Strados Labs, a medical technology company, is announcing the launch of a new grant initiative developed to accelerate...
Regulatory Pathways for Cough Monitoring in Clinical Trials: FDA Validation Requirements Explained
Cough monitoring has emerged as an increasingly common practice in research studies and drug development in recent years to objectively measure changes in subjects' cough. As drug developers consider including cough frequency as an endpoint in their studies,...
Let's Talk
Speak to one of our respiratory experts to learn more